Jul 30, 2021 2:09 AM
BACK TO TOP
KSE100
47,312.33
-5.70
(-0.01%)
ALLSHR
32,270.88
-37.40
(-0.12%)
KSE30
18,963.44
-10.86
(-0.06%)
KMI30
76,544.57
97.42
(0.13%)
BKTi
12,750.39
-61.64
(-0.48%)
OGTi
12,241.34
-13.17
(-0.11%)
KMIALLSHR
23,092.04
6.38
(0.03%)
UPP9
13,192.76
-28.63
(-0.22%)
NITPGI
9,734.07
-10.22
(-0.10%)
NBPPGI
11,753.83
-11.69
(-0.10%)
MZNPI
11,043.57
1.82
(0.02%)
Citi Pharma Ltd.
PHARMACEUTICALS
Rs.40.00
1.08
(2.77%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Thu, Jul 29, 2021 4:07 PM
REG
FUT
ODL
Open
38.90
High
40.48
Low
38.41
Volume
6,207,000
CIRCUIT BREAKER
36.00 — 41.84
DAY RANGE
38.41 — 40.48
52-WEEK RANGE
32.00 — 40.48
Ask Price
0.00
Ask Volume
0
Bid Price
40.00
Bid Volume
270,500
LDCP
38.92
VAR
25.00
HAIRCUT
32.50
P/E Ratio (TTM) **
10.31
1-Year Change *
2.77%
YTD Change *
2.77%
Open
39.01
High
39.80
Low
38.01
Close
39.35
Change
1.10%
LDCP
38.92
Volume
5,313
Total Trades
121
CIRCUIT BREAKER
35.03 — 42.81
DAY RANGE
38.01 — 39.80
Ask Price
39.75
Ask Volume
25
Bid Price
39.35
Bid Volume
5
Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.

KEY PEOPLE
Mr. Rizwan SheikhCEO
Mr. Nadeem AmjadChairman
Mr. Muhammad RiazCompany Secretary
ADDRESS

Corporate Office: 588-Q Block, Johar Town, Lahore

WEBSITE

www.citipharma.com.pk

AUDITOR

Aslam Malik & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
8,307,680.00
Shares
207,692,000
Free Float
72,692,000
Free Float
35.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
DateTitleDocument
DateTitleDocument
Jul 27, 2021Change of Director View   
Jul 14, 2021Material Information View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2020201920182017
Sales3,527,6252,607,0282,003,3341,592,059
Profit after Taxation145,63527,804116,86684,891
EPS32.366.1825.9718.86
Q3 2021Q2 2021Q1 2021Q3 2020
Sales4,015,415
Profit after Taxation252,436
EPS3.88
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2020201920182017
Gross Profit Margin (%)12.4612.6913.1213.10
Net Profit Margin (%)4.131.075.835.33
EPS Growth (%)423.62(76.20)37.7055.10

Payouts

Financial Reports